Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Williams

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
The Journal of Clinical Investigation|November 5, 1999
Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirusB G Harvey, P L Leopold, N R Hackett, et al.
Diabetes|August 12, 2021
ENTPD3 Marks Mature Stem Cell-Derived β-Cells Formed by Self-Aggregation In VitroFiona M Docherty, Kent A Riemondy, Roberto Castro-Gutierrez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol QK L Jhaveri, X V Wang, V Makker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 8, 2021
Corrigendum to 'Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q': [Annals of Oncology 30 (2019) 1821-1830]K L Jhaveri, X V Wang, V Makker, et al.
NPJ Precision Oncology|March 2, 2022
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trialA S Mansfield, Z Wei, R Mehra, et al.
Genomics|December 12, 2001
Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraineL C McCarthy, D A Hosford, J H Riley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2023
Erratum to "Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project": [Annals of Oncology 32 (2021) 1626-1636]D M Vega, L M Yee, L M McShane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 4, 2021
Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization ProjectD M Vega, L M Yee, L M McShane, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
The Journal of Clinical Investigation|November 5, 1999
Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirusB G Harvey, P L Leopold, N R Hackett, et al.
Diabetes|August 12, 2021
ENTPD3 Marks Mature Stem Cell-Derived β-Cells Formed by Self-Aggregation In VitroFiona M Docherty, Kent A Riemondy, Roberto Castro-Gutierrez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol QK L Jhaveri, X V Wang, V Makker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 8, 2021
Corrigendum to 'Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q': [Annals of Oncology 30 (2019) 1821-1830]K L Jhaveri, X V Wang, V Makker, et al.
NPJ Precision Oncology|March 2, 2022
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trialA S Mansfield, Z Wei, R Mehra, et al.
Genomics|December 12, 2001
Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraineL C McCarthy, D A Hosford, J H Riley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2023
Erratum to "Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project": [Annals of Oncology 32 (2021) 1626-1636]D M Vega, L M Yee, L M McShane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 4, 2021
Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization ProjectD M Vega, L M Yee, L M McShane, et al.
Pageof 10